BiotechTube
Home/Infinimmune/Katie Pfeiffer, PhD
KP

Katie Pfeiffer, PhD

Chief Technology Officer & Co-Founder

Infinimmune

Therapeutic Areas

ImmunologyInflammationDermatologyNephrologyGastroenterology

Infinimmune Pipeline

DrugIndicationPhase
IFX-101Moderate-to-Severe Atopic Dermatitis (msAD)Preclinical
IFX-201Moderate-to-Severe Atopic Dermatitis (msAD)Preclinical
IFX-301IgA Nephropathy (IgAN)Preclinical
IFX-401Ulcerative Colitis (UC)Preclinical
IFX-501UndisclosedUndisclosed
Immunome PartnershipUndisclosedUndisclosed

Leadership Team at Infinimmune

WM
Wyatt McDonnell, PhD
CEO & Co-Founder
MG
Mike Gibbons, PhD
Chief Scientific Officer & Co-Founder
TS
Tim Sullivan, PhD
Chief Business Officer
LH
Lance Hepler, PhD
Chief Information Officer & Co-Founder
View full Infinimmune profile